Patient-applied treatment for genital warts: Experience from a large postmarketing study

Safety and Efficacy of 0.5% Podofilox Gel in the Treatment of Anogenital Warts

“…Following its introduction in the United States, a large, postapproval study of 0.5% podofilox topical solution in more than 1300 patients further demonstrated its efficacy and safety in the real-life clinical setting. 13 This study also demonstrated a patient preference for selftreatment with 0.5% podofilox solution over other treatments, primarily because of the added convenience to the patient.…”

Human papillomavirus–related genital disease in the immunocompromised host

“…Podophyllotoxin, also called podofilox, is another patient-applied treatment option that has been shown to be safe and effective in the treatment of anogenital warts (level IA evidence). [28][29][30] Preparations are inexpensive and relatively fast-acting, making them a preferred first-line treatment by some clinicans. 31 Podophyllotoxin's effects are mediated through blocking polymerization of tubulin into microtubules, thereby arresting mitosis.…”